Dear Customers,
Following news of the voluntary administration of Aridol’s Australian manufacturer, and the subsequent stock issues, clinics unable to obtain Aridol (mannitol) have approached Bird Healthcare about methacholine challenge testing. We have subsequently seen a significant increase in demand for AeroEclipse breath actuated nebuliser heads.
We are in the process of arranging additional stock for the Australian market. If your clinic requires supply of this product, we ask you please advise your anticipated quantities and timeframes so we can coordinate with the manufacturer in the US and plan sufficient stock across all services.
Our focus is supporting clinics to maintain testing and continuity of patient care during this disruption, until there is hopefully a recommencement of Aridol production in the near future.
Please reach out to your local representative to communicate any needs you may have, or for more information on the AeroEclipse breath actuated nebuliser heads.
Bird Healthcare